Meyka AI API is live for developers.Start building.
Advertisement
Nephros, Inc.

Nephros, Inc. (NEPH) Stock Overview

Explore Nephros, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NEPHNASDAQ
HealthcareMedical - Instruments & Supplies
$3.42
$0.17(4.74%)
U.S. Market opens in 47h 38m
Advertisement

Nephros, Inc. (NEPH)

Meyka AI Score

Z

Key Financials

Market Cap37.1M
P/E Ratio46.53
EPS (TTM)$0.07
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$1.97
3 Months$4.91
1 Year Target$6.57

NEPH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nephros, Inc. (NEPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.18, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 46.53 and a market capitalization of 37.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.74%
5-Day Change
-7.57%
1-Month Change
8.92%
3-Month Change
-12.08%
6-Month Change
-39.47%
Year-to-Date (YTD) Change
-29.92%
1-Year Change
0.59%
3-Year Change
90.00%
5-Year Change
-62.95%
All-Time (Max) Change
-99.68%

Contact Information

201 343 5202
380 Lackawanna Place, South Orange, NJ, 07079

Company Facts

31 Employees
IPO DateSep 21, 2004
CountryUS
Actively Trading

Frequently Asked Questions